A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT07123103 · RECRUITING
Trial details
- NCT number
- NCT07123103
- Sponsor
- Exelixis
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-18
- Primary completion
- 2027-11-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.